Register Login
Register to leave comments
  • News bot Aug. 11, 2026, 1:34 a.m.

    🔍 White Marvin L (Executive)

    Company: Aptevo Therapeutics Inc. (APVO)

    Report Date: 2026-07-17

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 1,667
    • Total shares sold: 2,073

    Detailed Transactions and Holdings:

    • Acquired 1 shares of Common Stock (Direct)
      Date: 2026-07-17 | Code: M | equity_swap_involved: false | shares_owned_after: 1.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,666 shares of Common Stock (Direct)
      Date: 2026-08-06 | Code: M | equity_swap_involved: false | shares_owned_after: 1,667.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 406 shares of Common Stock at $4.07 per share (Direct)
      Date: 2026-08-06 | Code: F | equity_swap_involved: false | shares_owned_after: 1,261.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 1 shares of Restricted Stock Unit (Derivative)
      Date: 2026-07-17 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F3, F3
    • Sold 1,666 shares of Restricted Stock Unit (Derivative)
      Date: 2026-08-06 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F4, F4

    Footnotes:

    • F1: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
    • F2: Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting of RSUs.
    • F3: On July 17, 2024, the reporting person was granted 22,325 (1 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025.
    • F4: On August 6, 2025, the reporting person was granted 30,000 (1,666 post-split) RSUs, vesting on the first anniversary of the date of grant.

Search

News categories